The impact of histopathology on nodal metastases in minimal breast cancer

Archives of Surgery

Volumn 132, Issue 4, 1997, Pages 384-391

  Mustafa, Isha A ^a   Cole, Bernard ^b   Wanebo, Harold J ^a   Bland, Kirby I ^a   Chang, Helena R ^a,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030901097     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430280058008     Document Type: Article

References (34)

1. McGuire WL, Clark GM. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med. 1992;326:1756-1761.
2. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin. 1993; 43:27-41.
3. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 1986;12:1575-1582.
4. Aitken D, Minton J. Complications associated with mastectomy. Surg Clin North Am. 1983;63:1331-1352.
5. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer. 1995;76:1491-1512.
6. Fisher B, Redmond C, Fisher E, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Meo. 1985;312:674-681.
7. Garter GL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer. 1989;63:181-187.
8. Holmberg L, Lindren A, Norden T, Adami HO, Bergstrom R. Age as a determinant of axillary node involvement in invasive breast cancer. Acta Oncol. 1994; 33:603-608.
9. Stierer M, Rosen HR, Weber R, Marczell A, Kornek GV, Czerwnka E. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynecol Obstet. 1992;175:151-160.
10. Halverson KJ, Taylor ME. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol. 1994;17:461-466.
11. Ciatto S, Del Turco R, Bonardi R, et al. Non-palpable lesions of the breast detected by mammography: review of 1182 consecutive histotogically confirmed cases. Eur J Cancer. 1994;30A:40-44.
12. Tinnemans JGM, Wobbes T, Holland R, Hendriks JHCL, Van der Sluis RF, De Boer HHM. Treatment and survival of female patients with nonpalpable breast carcinoma. Ann Surg. 1989;209:249-253.
13. Silverstein MH, Gierson ED, Waisman JR, Colburn WJ, Gamagami I. Predicting axillary node positivity in patients with invasive carcinoma of the breast using a combination of T category and palpability. J Am Coll Surg. 1995;180: 700-704.
14. Scnabel FR, Estabrook A. Results of axillary lymph node dissection in early breast cancer. Breast Cancer Res Treat. 1994;32(suppl):40, Abstract.
15. Seidman JD, Schnapper LA. Aisner SC. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastases. Cancer. 1995;75:65-71.
16. Ahlgren J, Stal O, Westmaan G, Arnesson L-G. Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncol. 1994; 33:603-608.
17. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol. 1993;11:1536-1544.
18. Ptaszynski A, Van den Bogaert W, Van Glabbeke M, et al. Patient population analysis in EORTC Trial 22881/10882 on the role of a booster dose in breast conserving therapy. Eur J Cancer. 1994;30A:2073-2081.
19. Chadha M, Chabon AD, Friedmaann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer: a multivariate analysis. Cancer. 1994;73:350-353.
20. Tabar L, Fagerberg C, Duffy SW, Day ME, Gau A, Gvöntott O. Update of the Swedish two-country program of mammographic screening for breast cancer. Radiol Clin North Am. 1992;30:187-210.
21. Arnesson L-G, Smeds S, Gagerberg G. Recurrence-free survival in patients with small breast cancers. Eur J Surg. 1994;160:271-276.
22. Meterissian SH, Singletary SE. Nonpalpable breast carcinoma: inability to predict axillary nodal metastases. Breast Cancer Res Treat 1993;27:157. Abstract.
23. Dowlatshahi K, Snider HC, Kim R. Axillary node status in nonpalpable breast cancer. Ann Surg Oncol. 1995;2:424-428.
24. White R, Vezeridis MP, Kostadoulakis M, Cole B, Wanebo JH, Bland KI. Therapeutic options and results for the management of minimally invasive breast cancer: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg. 1996;183:575-582.
25. Rosen PP, Groshen S, Kinne DW, Norton L. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol. 1993;11:2090-2100.
26. Rosen PP, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0): assessment of 644 patients with median follow-up of 18 years. Surg Clin North Am. 1990;70:937-962.
27. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg. 1993;218:338-349.
28. Rosen PP, Groshen S, Saigo PE, Kinne W, Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinomas: a study of 644 patients with median follow-up of 18 years. J Clin Oncol. 1989;7:1239-1251.
29. Reger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg. 1989;157:501-502.
30. Rosen PP, Saigo PE, Braun DW, Weathers E, Kinne DW. Prognosis in stage II (T1N1M0) breast cancer. Ann Surg. 1981;194:576-584.
31. Rosen PP, Saigo PE, Braun DW, Weathers E, DePalo A. Predictors of recurrence in stage I (T1N0M0) breast carcinoma. Ann Surg. 1981;193:15-25.
32. Chung M, Chung HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996;7:97-103.
33. Cabanes PA, Salamon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lympectomy and radiotherapy in early breast cancer. Lancet. 1992; 339:1245-1248.
34. Ravdin PM, DeLaurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst. 1994;86:1771-1775.